These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 11677980
1. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection. Ueno H, Okada S, Okusaka T, Ikeda M, Tanaka N, Sakamoto M, Yoshimori M. Hepatogastroenterology; 2001; 48(41):1430-4. PubMed ID: 11677980 [Abstract] [Full Text] [Related]
2. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate. Dohmen K, Shirahama M, Shigematsu H, Miyamoto Y, Torii Y, Irie K, Ishibashi H. Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976 [Abstract] [Full Text] [Related]
3. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, Nishimura A, Yamashiki N, Okamura A, Inoue K. Cancer; 1999 Apr 15; 85(8):1694-702. PubMed ID: 10223562 [Abstract] [Full Text] [Related]
4. Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma. Ishii H, Okada S, Nose H, Okusaka T, Nagahama H, Nakayama H, Nakasuka H, Yoshimori M. Hepatogastroenterology; 1996 Apr 15; 43(10):938-43. PubMed ID: 8884317 [Abstract] [Full Text] [Related]
5. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Castells A, Bruix J, Bru C, Fuster J, Vilana R, Navasa M, Ayuso C, Boix L, Visa J, Rodés J. Hepatology; 1993 Nov 15; 18(5):1121-6. PubMed ID: 8225217 [Abstract] [Full Text] [Related]
6. The use of percutaneous ethanol injection therapy for recurrence of hepatocellular carcinoma. Kotoh K, Sakai H, Morotomi I, Nawata H. Hepatogastroenterology; 1995 Jul 15; 42(3):197-200. PubMed ID: 7590564 [Abstract] [Full Text] [Related]
7. Appraisal of combination treatment for hepatocellular carcinoma: long-term follow-up and lipiodol-percutaneous ethanol injection therapy. Tateishi H, Oi H, Masuda N, Yano H, Matsui S, Kinuta M, Maruyama H, Yayoi E, Okamura J. Semin Oncol; 1997 Apr 15; 24(2 Suppl 6):S6-81-S6-90. PubMed ID: 9151921 [Abstract] [Full Text] [Related]
11. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Ohnishi K. Hepatogastroenterology; 1998 Aug 15; 45 Suppl 3():1254-8. PubMed ID: 9730384 [Abstract] [Full Text] [Related]
12. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma. Peng ZW, Zhang YJ, Chen MS, Liang HH, Li JQ, Zhang YQ, Lau WY. Surg Oncol; 2008 Jul 15; 17(1):23-31. PubMed ID: 17869095 [Abstract] [Full Text] [Related]
13. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Kotoh K, Sakai H, Sakamoto S, Nakayama S, Satoh M, Morotomi I, Nawata H. Am J Gastroenterol; 1994 Feb 15; 89(2):194-8. PubMed ID: 8304302 [Abstract] [Full Text] [Related]
14. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Yamamoto J, Okada S, Shimada K, Okusaka T, Yamasaki S, Ueno H, Kosuge T. Hepatology; 2001 Oct 15; 34(4 Pt 1):707-13. PubMed ID: 11584366 [Abstract] [Full Text] [Related]